SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

Repeated Sui mainnet outages and transaction halts are driving concern about the networks reliability, with traders debating whether the incidents undermine confidence in the protocol. Bulls view the selloff and token unlock overhang as accumulation opportunities, while skeptics cite outages, tokenomics, and asset-freezing concerns despite interest in gasless stablecoin transfers and institutional use cases.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is drawing attention after a sharp rally attributed by traders to the launch of confidential perpetual contracts powered by Hyperliquid, alongside renewed interest in its AI-agent and chain-abstraction positioning. Sentiment is broadly bullish, though some traders view the move as liquidity- or short-squeeze-driven and warn of technical resistance and a possible pullback.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Institutional and real-world-asset tokenization developmentsparticularly discussion of NYSE/ICE testing Avalanche for 24/7 tokenized securities tradingare driving attention alongside a high-volume rebound. Traders remain divided, with bulls citing adoption and corporate partnerships while skeptics point to weak token economics, limited fee revenue, and repeated pump-and-dump-style selloffs.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is drawing attention as traders debate whether its recent recovery can break through resistance near the upper-$50s and extend higher, with bullish users citing rising volume, short-covering potential and an anticipated altcoin rotation. Skeptics counter that LTC has repeatedly underperformed peers and may be staging another short-lived pump rather than a durable breakout.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARKK is drawing attention as traders track ARK Invests repeated accumulation of SpaceX exposure across its funds, alongside signs of a potential breakout in high-beta growth stocks. Bulls view the activity as confirmation of renewed risk appetite, while critics argue that the SpaceX concentration and ARKKs long-term underperformance reflect poor portfolio management.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Speculation around forthcoming crypto regulatory clarity, SEC/CFTC action, and institutional tokenization initiatives such as DTCC and stablecoin adoption is driving bullish interest in XLM. Traders remain divided, with supporters expecting a breakout while critics point to repeated selloffs and the tokens inability to sustain moves above a key round-number resistance level.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

A sharp rebound with elevated trading activity has put Algorand back in focus, as traders point to bullish technical momentum alongside its new leadership, post-quantum upgrades, and tokenization potential. The community remains divided, with bulls expecting a broader altcoin recovery while skeptics cite dilution, weak adoption, and repeated failed rallies.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

A reported U.S.-Denmark-Greenland security agreement, including restrictions on adversary military presence and sensitive investments, has renewed attention on CRMLs Tanbreez rare-earth project and broader critical-minerals supply-chain themes. Traders largely view the news as bullish and anticipate short covering, while skeptics note that it is not a direct mining or offtake agreement and does not change the projects development timeline.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Speculation around higher LUNC burns, including Binance activity and the proposed Market Module 2.0, is driving hopes for supply reduction and a future USTC repeg. Traders are divided between bullish holders expecting ecosystem developments and renewed momentum, and skeptics who point to LUNCs large supply, weak follow-through, and grid-bot-driven trading.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas personalized mRNA cancer vaccine, used with Keytruda, met key Phase 3 endpoints in resected melanoma, drawing attention to Mercks oncology pipeline and potential support beyond the Keytruda patent cliff. Traders are debating whether the rally fully reflects the opportunity, noting that detailed data, overall-survival results, regulatory review, and broader-cancer applicability remain unresolved.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This Lyell Immunopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Wall Street analysts change outlook on top names. Check analyst ratings page for all changes. See what analysts say about LYEL, IMRX, and RNA.read more...

Wall Street Analysts Think Lyell Immunopharma (LYEL) Could Surge 176.02%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 176% in Lyell Immunopharma (LYEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Lyell Immunopharma Issues Colorectal Cancer Drug Safety Update

Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advances study to Phase 1/2 design.read more...

Lyell Immunopharma (LYEL) Loses 39.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Lyell Immunopharma (LYEL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL)

Lyell Immunopharma (LYEL) to Release Quarterly Earnings on Tuesday

Lyell Immunopharma (NASDAQ:LYEL) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-lyell-immunopharma-inc-stock...

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, three have iss...

Lyell Immunopharma (NASDAQ:LYEL) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen cut shares of Lyell Immunopharma from a "hold" rating to a "sell" rating in a research note on Saturday...

Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down - Here's What Happened

Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down - Here's What Happened...

Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen upgraded Lyell Immunopharma from a "sell" rating to a "hold" rating in a research note on Saturday...

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Lyell Immunopharma Inc

WisdomTree, Lyell Immunobiopharma, DexCom Among Stocks Retailers Are Most Bullish In Friday's Premarket

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$11.01
Prev Close	$10.80
Open	$10.75
Dividend Yield	0.00%
50-Day Moving Average	$13.64
Beta	1.57
Avg. Volume	156,326.56
PE Ratio	-0.94

52-Week High	$45.00
52-Week Low	$10.46
Market Capitalization	$269.8M
EPS (Annual)	-$16.06
Price to Book	1.10
Revenue Per Employee	$223.60

Feed

News

Sentiment

Earnings

Fundamentals

Info

LYEL Fundamentals